Table 6.
Therapeutic modalities for drugs administration to treat back-pain in 2016 survey | 0–10% of cases n (%) | 10–20% of cases n (%) | 20–40% of cases n (%) | 40–60% of cases n (%) | 60–80% of cases n (%) | 80–90% of cases n (%) | 90–100% of cases n (%) |
---|---|---|---|---|---|---|---|
IM or IV route | 70 (41) | 45 (27) | 32 (19) | 10 (6) | 7 (4) | 2 (1) | 3 (2) |
Medication between spinous processes | 29 (17) | 40 (24) | 45 (27) | 20 (12) | 7 (4) | 17 (10) | 10 (6) |
Mesotherapy | 39 (23) | 24 (14) | 18 (11) | 20 (12) | 25 (15) | 27 (16) | 15 (9) |
Paravertebral injection | 30 (18) | 42 (25) | 30 (18) | 34 (20) | 15 (9) | 15 (9) | 2 (1) |
Sacro-iliac joint injection | 84 (50) | 37 (22) | 17 (10) | 13 (8) | 8 (5) | 5 (3) | 3 (2) |
US-guided medication of the TL articular facets | 66 (39) | 22 (13) | 25 (15) | 20 (12) | 8 (5) | 15 (9) | 12 (7) |
US-guided sacro-iliac joint medication | 52 (31) | 34 (20) | 27 (16) | 25 (15) | 7 (4) | 13 (8) | 10 (6) |
IM, intramuscular; IV, intravenous; TL, thoracolumbar. Frequently reported percentage (>35%) are given in bold font.